Comparative evaluation of the safety and efficacy of long term use of anti-cholinergic, Imidafenacin and Solifenacin, on overactive bladder: a prospective randomized trial.

Trial Profile

Comparative evaluation of the safety and efficacy of long term use of anti-cholinergic, Imidafenacin and Solifenacin, on overactive bladder: a prospective randomized trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2011

At a glance

  • Drugs Imidafenacin (Primary) ; Solifenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms LIST
  • Most Recent Events

    • 02 Sep 2011 Results presented at the 41st Annual Meeting of the International Continence Society.
    • 13 Apr 2011 Status changed from active, no longer recruiting to completed.
    • 13 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top